Ground News

institutional access

You are connecting from
Lake Geneva Public Library,
please login or register to take advantage of your institution's Ground News Plan.

BioProcess International image

News from BioProcess International

See all of BioProcess International news coverage in one place. Discover how BioProcess International’s media bias informs their coverage and compare with thousands of other news outlets.

Ground News has come across 90 headlines reported on by BioProcess International during the past 3 months.

BioProcess International’s aggregated media bias check is unknown. Ground News is unable to assign a bias rating and does not have ratings available from Ad Fontes Media, All Sides, and Media Bias/Fact Check.

BioProcess International’s aggregated factuality score is Unknown. Factuality is assigned by combining fact check, credibility, and reliability ratings from Ad Fontes Media and Media Bias/Fact Check.

Information about BioProcess International

Where is BioProcess International located?BioProcess International's Website

Media Bias Ratings

Do you diasgree?

Edit bias

Learn more about Media Bias Ratings.

Factuality

Learn more about Factuality Ratings

Reveal Factuality Ratings by upgrading to a Premium account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Ownership

Learn more about Ownership categories

Reveal Ownership Data by upgrading to a Vantage account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Top BioProcess International News

UCB Announces Major U.S. Investment to Expand Biologics Manufacturing Capacity

Infrastructure · United States

UCB Announces Major U.S. Investment to Expand Biologics Manufacturing Capacity

83% Center coverage: 6 sources

/PRNewswire/ -- UCB, a global biopharmaceutical company focused on improving the lives of people with severe diseases, today announced plans for a significant...See the Story

BioProcess International June 2025: Upstream Production Issue 2025 - June

BioProcess International June 2025: Upstream Production Issue 2025 - June

June 2025 Upstream Production issue of BioProcess International.Read Article

Cytiva Completes $1.6 Billion in Strategic Investments to Further Enhance Global Supply Chain

Uppsala · Uppsala

Cytiva Completes $1.6 Billion in Strategic Investments to Further Enhance Global Supply Chain

Officials at Cytiva report that the company has completed significant expansion projects in several locations in the U.S., Europe, and Asia as part of its ongoing commitment to customers developing and manufacturing advanced therapeutics. Set to continue through 2028, these expansions will meet increased customer demand as part of Cytiva’s long-term growth plan and in-region manufacturing strategy, supported by an investment of $1.6 billion sinc…See the Story

Biologics and Biosimilars Differ in Composition Due to Variability in Biological Manufacturing Processes

Biopharmaceutical products have significantly transform […] The post Biologics and Biosimilars Differ in Composition Due to Variability in Biological Manufacturing Processes first appeared on GeneOnline News. The post Biologics and Biosimilars Differ in Composition Due to Variability in Biological Manufacturing Processes appeared first on GeneOnline News.Shell See the Story

Sanofi accelerates Beyfortus shipping and manufacturing ahead of RSV season

The firm shipped millions of doses last year and is sending doses to more than 40 countries for 2025-2026.Read Article

OS Therapies partners with EVERSANA ahead of projected immunotherapy launch

The developer has also partnered with a European manufacturer, which has scaled up the manufacturing process.Read Article

WuXi Biologics announces Virogen and VISEN manufacturing projects at new Chengdu facility

The CDMO announces strategic partnerships with Virogen Biotechnology for VG712 manufacturing and VISEN Pharmaceuticals for lonapegsomatropin production, strengthening its position in advanced biologics manufacturing.Chengdu · Chengdu Read Article

Regeneron poised to overcome FDA setbacks thanks to expanded manufacturing capabilities

Regeneron poised to overcome FDA setbacks from complete response letters thanks to expanded manufacturing capabilities, including $3 billion deal with Fujifilm.Fujifilm · United States Read Article

CRISPR discusses CASGEVY growth and future of allogeneic CAR-T therapies

CRISPR Therapeutics CEO outlines plans to expand allogeneic CAR-T therapies for autoimmune diseases while scaling CASGEVY's global reach across eight jurisdictions with a $2.2M price pointCRISPR Read Article

BioNet and Bio Farma forge vaccine alliance to bolster ASEAN healthcare

BioNet and Bio Farma's strategic vaccine partnership aims to deliver up to 15 million annual doses across ASEAN for critical tetanus, diphtheria, and pertussis immunizations.ASEAN Read Article

Zydus enters global biologics CDMO market with $75m Agenus facility acquisitions

The deal includes exclusive manufacturing rights for Agenus's cancer immunotherapies.Cancer Read Article

Breaking News Topics Related to BioProcess International

Our use of cookiesCookie policy

Unlike other news sites, we do not share or sell your data to third-parties for targeted ads. In fact, the Ground News application and website do not run any ads at all. Our application and website use cookies and similar technologies to personalize content we deliver to you and also allows us to improve your usage of our platform through analytics. These cookies help us provide the best experience possible. Learn more about cookies and preference selection here.

By continuing to use our application or website, you agree to our Terms of Service and Privacy Policy.